« Back to Record
Citation APA

Zwierzina, H., Suciu, S., Loeffler, J. S., Neuwirtova, R., Fenaux, P., Beksac, M. S., Harousseau, J.-L., Nuessler, V., Cermak, J., Solbu, G., Willemze, R., De Witte, T., Amadori, S., Stryckmans, P., Bron, D., Louwagie, A., Selleslag, D., Peetermans, M., Berneman, Z. N., Coiffier, B., Thyss, A., Bourhis, J., Fiere, D., Zittoun, R. A., Marie, J. P., Maraninchi, D., Baumelou, É., Lowenberg, B., Sonnenveld, P., Gerhartz, H., Ribeiro, M. M., Ben-Bassat, I., Labar, B., & Dardenne, M. (2005). Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/ macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: Final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group. Leukemia, 19(11), 1929-1933. doi:10.1038/sj.leu.2403934


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/89848

Zwierzina, H., Suciu, S., Loeffler, J. S., Neuwirtova, R., Fenaux, P., Beksac, M. S., Harousseau, J.-L., Nuessler, V., Cermak, J., Solbu, G., Willemze, R., De Witte, T., Amadori, S., Stryckmans, P., Bron, D., Louwagie, A., Selleslag, D., Peetermans, M., Berneman, Z. N., Coiffier, B., Thyss, A., Bourhis, J., Fiere, D., Zittoun, R. A., Marie, J. P., Maraninchi, D., Baumelou, É., Lowenberg, B., Sonnenveld, P., Gerhartz, H., Ribeiro, M. M., Ben-Bassat, I., Labar, B., & Dardenne, M. (2005). Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/ macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: Final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group. Leukemia, 19(11), 1929-1933. doi:10.1038/sj.leu.2403934